Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Magnetic Resonance Imaging-Based Prostate Cancer Screening: Is High-Value Care Achieved or Does the Holy Grail Remain Elusive?

Wilt TJ, Dahm P.

JAMA Netw Open. 2018 Jun 1;1(2):e180220. doi: 10.1001/jamanetworkopen.2018.0220. No abstract available.

PMID:
30646064
3.

Clinical examination or whole-body magnetic resonance imaging: the Holy Grail of spondyloarthritis imaging.

Rennie WJ.

Arthritis Res Ther. 2012 Feb 29;14(1):110. doi: 10.1186/ar3737. No abstract available.

4.

A Pilot Study to Evaluate the Role of Magnetic Resonance Imaging for Prostate Cancer Screening in the General Population.

Nam RK, Wallis CJ, Stojcic-Bendavid J, Milot L, Sherman C, Sugar L, Haider MA.

J Urol. 2016 Aug;196(2):361-6. doi: 10.1016/j.juro.2016.01.114. Epub 2016 Feb 13.

PMID:
26880413
5.

The elusive "holy grail" of organizational culture and the power of like.

Fernandez CS.

J Public Health Manag Pract. 2015 Jul-Aug;21(4):406-9. doi: 10.1097/PHH.0000000000000281. No abstract available.

PMID:
26010693
6.
7.

Optimizing an individual's treatment in acute stroke: is a magnetic resonance map leading us towards the holy grail?

Levine SR.

J Neurol Sci. 2004 Oct 15;225(1-2):1-2. No abstract available.

PMID:
15465078
8.

Biochemical and imaging biomarkers: the search for the Holy Grail.

Plebani M.

Clin Chem Lab Med. 2010 Aug;48(8):1055-6. doi: 10.1515/CCLM.2010.199. No abstract available.

PMID:
20604731
9.

Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study.

Thompson JE, Moses D, Shnier R, Brenner P, Delprado W, Ponsky L, Pulbrook M, Böhm M, Haynes AM, Hayen A, Stricker PD.

J Urol. 2014 Jul;192(1):67-74. doi: 10.1016/j.juro.2014.01.014. Epub 2014 Feb 8.

PMID:
24518762
10.

David Oliver: Is hospital avoidance an elusive holy grail?

Oliver D.

BMJ. 2019 Feb 19;364:l746. doi: 10.1136/bmj.l746. No abstract available.

PMID:
30782601
11.

PSA kinetics and risk of death from prostate cancer: in search of the Holy Grail of surrogate end points.

Anscher MS.

JAMA. 2005 Jul 27;294(4):493-4. No abstract available.

PMID:
16046657
12.

'Health for All' Alma-Ata Declaration--an elusive Holy Grail.

Ncayiyana DJ.

S Afr Med J. 2008 Sep;98(9):655. No abstract available.

PMID:
19113038
13.
14.

Screening for prostate cancer: opportunities and challenges.

Thompson IM, Bermejo C, Hernandez J, Basler JA, Canby-Hagino E.

Surg Oncol Clin N Am. 2005 Oct;14(4):747-60. Review.

PMID:
16226689
15.
16.

Taxing sugar-sweetened beverages: not a "holy grail" but a cup at least half comment on "food taxes: a new holy grail?".

Block JP, Willett WC.

Int J Health Policy Manag. 2013 Aug 8;1(2):183-5. doi: 10.15171/ijhpm.2013.33. eCollection 2013 Aug.

17.

The Holy Grail and the quest for the gold standard.

Rumboldt Z.

AJNR Am J Neuroradiol. 2010 Oct;31(9):1617-8. doi: 10.3174/ajnr.A2149. Epub 2010 Jun 25. No abstract available.

18.

Screening for malignant mesothelioma--looking for the holy grail.

Grigoriu B, Scherpereel A.

Am J Respir Crit Care Med. 2009 May 1;179(9):851; author reply 851-852. No abstract available.

PMID:
19383930
19.

Current Ability of Multiparametric Prostate Magnetic Resonance Imaging and Targeted Biopsy to Improve the Detection of Prostate Cancer.

Raskolnikov D, Rais-Bahrami S, Turkbey B, Rastinehad AR, Choyke PL, Wood BJ, Pinto PA.

Urol Pract. 2014 May;1(1):13-21. doi: 10.1016/j.urpr.2014.02.012. Epub 2014 Mar 4.

20.

Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer.

Rais-Bahrami S, Siddiqui MM, Turkbey B, Stamatakis L, Logan J, Hoang AN, Walton-Diaz A, Vourganti S, Truong H, Kruecker J, Merino MJ, Wood BJ, Choyke PL, Pinto PA.

J Urol. 2013 Nov;190(5):1721-1727. doi: 10.1016/j.juro.2013.05.052. Epub 2013 May 29.

Supplemental Content

Support Center